Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections
作者:
S. Scalambrino,
C. Mangioni,
R. Milani,
M. Regallo,
S. Norchi,
L. Negri,
S. Carrera,
E.F. Vigano,
M.P. Ruffilli,
M.P. Canale,
期刊:
International Journal of Gynecology&Obstetrics
(WILEY Available online 2005)
卷期:
Volume 29,
issue Supplement
页码: 21-27
ISSN:0020-7292
年代: 2005
DOI:10.1016/0020-7292(89)90088-X
出版商: Wiley
数据来源: WILEY
摘要:
AbstractIn an open, randomized clinical study, the safety and efficacy of sulbactam/ampicillin was compared to that of cefotetan in 95 hospital patients with gynecologic or obstetric infections. Sulbactam/ampicillin (1 g:2 g), was administered intravenously every 8 h to 46 patients, and cefotetan (2 g) was administered intravenously every 12 h to 49 patients. All 23 patients with obstetric infections and 18 of the 23 patients with gynecologic infections treated with sulbactam/ampicillin were evaluated as cured. All 21 patients with obstetric infections and 23 of the 28 patients with gynecologic infections treated with cefotetan were evaluated as cured. No side effects requiring discontinuation of therapy or reduction of the dose administered, were observed.
点击下载:
PDF
(371KB)
返 回